Abstract: Previous studies established that oral glutamine (GLN) reduced tumor development in implantable and 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer models. This finding was ...
| Attachment | Size |
|---|---|
| Modulation of p53 and c-myc in DMBA-Induced Mammary Tumors by Oral Glutamine.pdf | 413.06 KB |
